Paranovus Entertainment Technology Ltd. (PAVS) 10-Year Financial Performance & Capital Metrics

PAVS • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessHerbal & Natural Health Products

AboutParanovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. Paranovus Entertainment Technology Ltd. was founded in 2004 and is headquartered in Nanping, the People's Republic of China.Show more

Revenue $72K -98.9%
EBITDA -$6M -51.0%
Net Income -$8M +22.1%
EPS (Diluted) -0.08 +96.4%
Gross Margin 12.6% +8921.0%
EBITDA Margin -8950.77% -13714.6%
Operating Margin -9481.93% -13327.5%
Net Margin -11033.03% -7030.9%
ROE -46.2% +56.6%
ROIC -27.06% +24.8%
Debt/Equity 0.08 -81.7%
Interest Coverage -25.91 +78.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Momentum leader: RS Rating 97 (top 3%)

✗Weaknesses

✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Sales declining 74.4% over 5 years
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-74.4%

3Y-90.72%

TTM-94.14%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM66.17%

EPS CAGR

10Y-

5Y-

3Y-

TTM98.72%

ROCE

10Y Avg5.54%

5Y Avg-29.21%

3Y Avg-31.36%

Latest-39.52%

Peer Comparison

Herbal & Natural Health Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NATRNature's Sunshine Products, Inc.	396.1M	22.64	56.60	2.03%	3.18%	9.05%	3.62%	0.09
BONBon Natural Life Limited	10.59M	1.74	10.24	-19.23%	6.45%	5.65%		0.16
PAVSParanovus Entertainment Technology Ltd.	1.34M	2.01	-25.77	-98.91%	-272.35%	-62.13%		0.08

Profit & Loss

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales/Revenue+	53M	61.5M	63.94M	65.06M	71.48M	89.49M	23.33M	6.54M	71.54K
Revenue Growth %	-	0.16%	0.04%	0.02%	0.1%	0.25%	-0.74%	-0.72%	-0.99%
Cost of Goods Sold+	27.18M	32.14M	31.69M	34.64M	53.31M	85.78M	93.1M	6.54M	62.53K
COGS % of Revenue	0.51%	0.52%	0.5%	0.53%	0.75%	0.96%	3.99%	1%	0.87%
Gross Profit+	25.82M	29.35M	32.25M	30.42M	18.18M	3.71M	416.88K	9.14K	9.02K
Gross Margin %	0.49%	0.48%	0.5%	0.47%	0.25%	0.04%	0.02%	0%	0.13%
Gross Profit Growth %	-	0.14%	0.1%	-0.06%	-0.4%	-0.8%	-0.89%	-0.98%	-0.01%
Operating Expenses+	8.61M	9.11M	10.4M	15.02M	16.65M	51.29M	4.97M	4.63M	6.79M
OpEx % of Revenue	0.16%	0.15%	0.16%	0.23%	0.23%	0.57%	0.21%	0.71%	94.95%
Selling, General & Admin	6.96M	7.25M	8.24M	12.66M	14.99M	49.6M	64.18M	2.82M	2.31M
SG&A % of Revenue	0.13%	0.12%	0.13%	0.19%	0.21%	0.55%	2.75%	0.43%	32.26%
Research & Development	1.66M	1.86M	2.16M	2.36M	1.66M	1.68M	1.4M	0	0
R&D % of Revenue	0.03%	0.03%	0.03%	0.04%	0.02%	0.02%	0.06%	-	-
Other Operating Expenses	0	0	103.77K	0	0	0	-60.61M	1.81M	4.48M
Operating Income+	17.21M	20.24M	21.84M	15.4M	1.53M	-47.58M	-4.55M	-4.62M	-6.78M
Operating Margin %	0.32%	0.33%	0.34%	0.24%	0.02%	-0.53%	-0.19%	-0.71%	-94.82%
Operating Income Growth %	-	0.18%	0.08%	-0.3%	-0.9%	-32.18%	0.9%	-0.02%	-0.47%
EBITDA+	17.33M	20.36M	22.53M	16.07M	2.41M	-45.39M	-4.49M	-4.24M	-6.4M
EBITDA Margin %	0.33%	0.33%	0.35%	0.25%	0.03%	-0.51%	-0.19%	-0.65%	-89.51%
EBITDA Growth %	-	0.17%	0.11%	-0.29%	-0.85%	-19.86%	0.9%	0.06%	-0.51%
D&A (Non-Cash Add-back)	125.92K	119.76K	682.46K	674.25K	880.88K	2.19M	58.75K	381.13K	380K
EBIT	17.51M	20.49M	21.99M	15.63M	1.76M	-57.66M	-4.53M	-3.75M	-6.74M
Net Interest Income+	-482.1K	-114.57K	-41.51K	-23.16K	20.1K	22.4K	316	-38.82K	-261.7K
Interest Income	11.62K	18.71K	42.04K	74.93K	131.9K	108.39K	316	345	156
Interest Expense	493.73K	133.28K	83.55K	98.09K	111.8K	85.99K	0	39.17K	261.85K
Other Income/Expense	-184.66K	120.85K	62.26K	133.41K	125.62K	-10.17M	22.04K	831.48K	-219.09K
Pretax Income+	17.02M	20.36M	21.91M	15.53M	1.65M	-57.75M	-4.53M	-3.79M	-7M
Pretax Margin %	0.32%	0.33%	0.34%	0.24%	0.02%	-0.65%	-0.19%	-0.58%	-97.88%
Income Tax+	2.5M	2.87M	3.18M	2.84M	959.38K	-3.73M	3K	0	0
Effective Tax Rate %	0.85%	0.86%	0.85%	0.82%	0.48%	0.85%	15.85%	2.67%	1.13%
Net Income+	14.52M	17.49M	18.72M	12.69M	786.36K	-49.19M	-71.74M	-10.13M	-7.89M
Net Margin %	0.27%	0.28%	0.29%	0.2%	0.01%	-0.55%	-3.07%	-1.55%	-110.33%
Net Income Growth %	-	0.2%	0.07%	-0.32%	-0.94%	-63.56%	-0.46%	0.86%	0.22%
Net Income (Continuing)	14.52M	17.49M	18.72M	12.69M	691.96K	-54.02M	-4.53M	-3.79M	-7M
Discontinued Operations	0	0	0	0	0	0	-67.66M	-6.14M	-1.3M
Minority Interest	0	0	0	0	2.89M	-710.75K	-886.01K	-412.18K	4.75M
EPS (Diluted)+	11.61	13.99	14.98	10.60	0.03	-24.30	-12.63	-2.14	-0.08
EPS Growth %	-	0.2%	0.07%	-0.29%	-1%	-811.01%	0.48%	0.83%	0.96%
EPS (Basic)	11.61	13.99	14.98	10.60	0.03	-24.30	-12.63	-2.14	-0.08
Diluted Shares Outstanding	1.25M	1.25M	1.25M	1.19M	26.16M	2.02M	5.68M	4.73M	84.51M
Basic Shares Outstanding	1.25M	1.25M	1.25M	1.19M	26.16M	2.02M	5.68M	4.73M	84.51M
Dividend Payout Ratio	-	0.48%	-	-	-	-	-	-	-

Balance Sheet

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Current Assets+	32.22M	43.76M	54.84M	69.98M	95.1M	56.57M	9.79M	2.85M	7.19M
Cash & Short-Term Investments	4.27M	8.88M	14.8M	33.65M	36.56M	19.73M	2.05M	944.24K	5.02M
Cash Only	4.27M	8.88M	14.8M	33.65M	36.56M	19.73M	3.36M	944.24K	261.36K
Short-Term Investments	0	0	0	0	0	0	0	0	4.76M
Accounts Receivable	24.14M	32.56M	32.01M	30.04M	34.56M	29.23M	2M	285.75K	0
Days Sales Outstanding	166.26	193.28	182.75	168.51	176.48	119.23	31.29	15.94	-
Inventory	3.73M	2.27M	1.97M	2.03M	1.79M	1.39M	335.02K	0	653.34K
Days Inventory Outstanding	50.04	25.77	22.7	21.38	12.22	5.91	1.31	-	3.81K
Other Current Assets	0	11.13K	6.06M	699.42K	3.07M	226.17K	4.17M	47.35K	12.21K
Total Non-Current Assets+	9.31M	9.64M	10.84M	15.11M	17.65M	40.86M	26.55M	4.88M	28.38M
Property, Plant & Equipment	8.52M	8.79M	7.81M	7.9M	10.51M	11.25M	8.47M	12.6K	126.44K
Fixed Asset Turnover	6.22x	7.00x	8.19x	8.24x	6.80x	7.96x	2.75x	519.60x	0.57x
Goodwill	0	0	0	0	162.83K	10.08M	6.46M	3.38M	17.5M
Intangible Assets	789.09K	847.5K	774.37K	719.72K	1.83M	10.1M	9.45M	1.49M	10.75M
Long-Term Investments	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	2.26M	6.5M	5.14M	5.63M	2.18M	0	0
Total Assets+	41.53M	53.4M	65.68M	85.1M	112.74M	97.43M	36.34M	7.73M	35.56M
Asset Turnover	1.28x	1.15x	0.97x	0.76x	0.63x	0.92x	0.64x	0.85x	0.00x
Asset Growth %	-	0.29%	0.23%	0.3%	0.32%	-0.14%	-0.63%	-0.79%	3.6%
Total Current Liabilities+	18.01M	8.84M	4.76M	5.51M	15.11M	17.93M	20.95M	2.56M	6.4M
Accounts Payable	6.06M	5.4M	1.66M	1.55M	8.84M	12.16M	13.46M	0	1.73M
Days Payables Outstanding	81.4	61.3	19.17	16.32	60.53	51.73	52.78	-	10.12K
Short-Term Debt	1.45M	1.49M	1.04M	2.03M	2.24M	2.27M	2.24M	2.29M	2.25M
Deferred Revenue (Current)	0	0	0	0	0	1000K	1000K	0	73.32K
Other Current Liabilities	10.21M	1.95M	2.06M	1.93M	4.02M	196.09K	122.78K	66.68K	0
Current Ratio	1.79x	4.95x	11.51x	12.71x	6.29x	3.15x	0.47x	1.11x	1.12x
Quick Ratio	1.58x	4.69x	11.10x	12.34x	6.18x	3.08x	0.45x	1.11x	1.02x
Cash Conversion Cycle	134.9	157.75	186.28	173.56	128.17	73.42	-20.18	-	-
Total Non-Current Liabilities+	209.01K	0	0	0	0	2.08M	1.51M	0	158.09K
Long-Term Debt	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	209.01K	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0	2.08M	1.51M	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	158.09K
Total Liabilities	18.21M	8.84M	4.76M	5.51M	15.11M	20.01M	22.47M	2.56M	6.56M
Total Debt+	1.95M	1.49M	1.04M	2.03M	2.24M	2.27M	2.24M	2.29M	2.35M
Net Debt	-2.32M	-7.39M	-13.76M	-31.62M	-34.32M	-17.47M	-1.11M	1.34M	2.09M
Debt / Equity	0.08x	0.03x	0.02x	0.03x	0.02x	0.03x	0.16x	0.44x	0.08x
Debt / EBITDA	0.11x	0.07x	0.05x	0.13x	0.93x	-	-	-	-
Net Debt / EBITDA	-0.13x	-0.36x	-0.61x	-1.97x	-14.26x	-	-	-	-
Interest Coverage	34.85x	151.86x	261.44x	156.99x	13.65x	-553.25x	-	-118.00x	-25.91x
Total Equity+	23.31M	44.55M	60.92M	79.59M	97.64M	77.41M	13.87M	5.17M	29M
Equity Growth %	-	0.91%	0.37%	0.31%	0.23%	-0.21%	-0.82%	-0.63%	4.61%
Book Value per Share	18.65	35.64	48.73	66.76	3.73	38.24	2.44	1.09	0.34
Total Shareholders' Equity	23.31M	44.55M	60.92M	79.59M	94.75M	78.13M	14.76M	5.58M	24.26M
Common Stock	11.5K	11.5K	11.5K	12.5K	15.24K	39.55K	83.3K	73.3K	673.3K
Retained Earnings	17.78M	35.27M	53.94M	66.62M	61.48M	12.29M	-59.45M	-61.96M	-70.26M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	1.02M	4.2M	1.27M	-2.09M	6.71M	11.93M	7.22M	2.55M	2.53M
Minority Interest	0	0	0	0	2.89M	-710.75K	-886.01K	-412.18K	4.75M

Cash Flow

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operations+	11.32M	12.93M	6.54M	10.78M	2.9M	-28.13M	-20.71M	-13.11M	-2.67M
Operating CF Margin %	0.21%	0.21%	0.1%	0.17%	0.04%	-0.31%	-0.89%	-2%	-37.31%
Operating CF Growth %	-	0.14%	-0.49%	0.65%	-0.73%	-10.69%	0.26%	0.37%	0.8%
Net Income	14.52M	17.49M	18.72M	12.69M	691.96K	-54.02M	-71.74M	-9.93M	-8.31M
Depreciation & Amortization	142.97K	137.17K	699.54K	690.75K	880.88K	2.19M	31.67K	381.13K	380K
Stock-Based Compensation	0	0	0	0	778.42K	1.09M	0	0	0
Deferred Taxes	0	0	0	0	2.56M	-3.92M	0	0	0
Other Non-Cash Items	3.78M	4.95M	-3.15K	117.79K	-2.56M	11.4M	51M	-2.4M	5.16M
Working Capital Changes	-3.34M	-4.69M	-12.87M	-2.72M	553.21K	15.13M	6.34K	-1.16M	100.12K
Change in Receivables	-4.35M	-6.55M	-1.6M	393.14K	-2.11M	23.22M	0	-11.36K	0
Change in Inventory	-184.4K	2.3M	148.39K	-276.91K	389.39K	454.26K	0	0	0
Change in Payables	1.13M	-1.19M	-3.38M	-32.72K	6.72M	-4.85M	0	0	0
Cash from Investing+	-1.1M	-157.97K	-277.16K	-1.16M	-13.22M	-8.48M	89.32K	11.7M	-27.05M
Capital Expenditures	-1.1M	-157.97K	-283.1K	-1.16M	-3.83M	-2.41M	0	0	0
CapEx % of Revenue	0.02%	0%	0%	0.02%	0.05%	0.03%	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	25.9K	89.32K	11.7M	-4.76M
Cash from Financing+	-8.43M	-8.78M	271.11K	10.4M	10.67M	18.83M	3.15M	0	29.01M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-8.33M	0	0	-375K	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-8.59M	221.42K	627.63K	0	37.52K	0	3.15M	0	1.85M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	10.22M	12.78M	6.26M	9.62M	-930.11K	-30.54M	-20.71M	-11.88M	-2.67M
FCF Margin %	0.19%	0.21%	0.1%	0.15%	-0.01%	-0.34%	-0.89%	-1.81%	-37.31%
FCF Growth %	-	0.25%	-0.51%	0.54%	-1.1%	-31.84%	0.32%	0.43%	0.78%
FCF per Share	8.17	10.22	5.01	8.07	-0.04	-15.09	-3.65	-2.51	-0.03
FCF Conversion (FCF/Net Income)	0.78x	0.74x	0.35x	0.85x	3.69x	0.57x	0.29x	1.29x	0.34x
Interest Paid	148.16K	133.28K	83.55K	98.09K	111.79K	0	0	0	0
Taxes Paid	2.33M	2.92M	3.01M	3.18M	1.21M	0	0	90.74K	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	62.27%	51.54%	35.5%	18.06%	0.89%	-56.2%	-157.17%	-106.36%	-46.2%
Return on Invested Capital (ROIC)	61.48%	52.21%	38.86%	24.28%	2.06%	-57.89%	-9.38%	-35.97%	-27.06%
Gross Margin	48.71%	47.73%	50.44%	46.75%	25.43%	4.15%	1.79%	0.14%	12.6%
Net Margin	27.39%	28.44%	29.28%	19.5%	1.1%	-54.97%	-307.47%	-154.72%	-11033.03%
Debt / Equity	0.08x	0.03x	0.02x	0.03x	0.02x	0.03x	0.16x	0.44x	0.08x
Interest Coverage	34.85x	151.86x	261.44x	156.99x	13.65x	-553.25x	-	-118.00x	-25.91x
FCF Conversion	0.78x	0.74x	0.35x	0.85x	3.69x	0.57x	0.29x	1.29x	0.34x
Revenue Growth	-	16.04%	3.97%	1.76%	9.87%	25.19%	-73.93%	-71.95%	-98.91%

Frequently Asked Questions

Growth & Financials

Paranovus Entertainment Technology Ltd. (PAVS) reported $6.6M in revenue for fiscal year 2024. This represents a 88% decrease from $53.0M in 2016.

Paranovus Entertainment Technology Ltd. (PAVS) saw revenue decline by 98.9% over the past year.

Paranovus Entertainment Technology Ltd. (PAVS) reported a net loss of $18.0M for fiscal year 2024.

Dividend & Returns

Paranovus Entertainment Technology Ltd. (PAVS) has a return on equity (ROE) of -46.2%. Negative ROE indicates the company is unprofitable.

Paranovus Entertainment Technology Ltd. (PAVS) had negative free cash flow of $14.5M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Paranovus Entertainment Technology Ltd. (PAVS) 10-Year Financial Performance & Capital Metrics

PAVS • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessHerbal & Natural Health Products

Revenue $72K -98.9%
EBITDA -$6M -51.0%
Net Income -$8M +22.1%
EPS (Diluted) -0.08 +96.4%
Gross Margin 12.6% +8921.0%
EBITDA Margin -8950.77% -13714.6%
Operating Margin -9481.93% -13327.5%
Net Margin -11033.03% -7030.9%
ROE -46.2% +56.6%
ROIC -27.06% +24.8%
Debt/Equity 0.08 -81.7%
Interest Coverage -25.91 +78.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Momentum leader: RS Rating 97 (top 3%)

✗Weaknesses

✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Sales declining 74.4% over 5 years
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-74.4%

3Y-90.72%

TTM-94.14%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM66.17%

EPS CAGR

10Y-

5Y-

3Y-

TTM98.72%

ROCE

10Y Avg5.54%

5Y Avg-29.21%

3Y Avg-31.36%

Latest-39.52%

Peer Comparison

Herbal & Natural Health Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NATRNature's Sunshine Products, Inc.	396.1M	22.64	56.60	2.03%	3.18%	9.05%	3.62%	0.09
BONBon Natural Life Limited	10.59M	1.74	10.24	-19.23%	6.45%	5.65%		0.16
PAVSParanovus Entertainment Technology Ltd.	1.34M	2.01	-25.77	-98.91%	-272.35%	-62.13%		0.08

Profit & Loss

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales/Revenue+	53M	61.5M	63.94M	65.06M	71.48M	89.49M	23.33M	6.54M	71.54K
Revenue Growth %	-	0.16%	0.04%	0.02%	0.1%	0.25%	-0.74%	-0.72%	-0.99%
Cost of Goods Sold+	27.18M	32.14M	31.69M	34.64M	53.31M	85.78M	93.1M	6.54M	62.53K
COGS % of Revenue	0.51%	0.52%	0.5%	0.53%	0.75%	0.96%	3.99%	1%	0.87%
Gross Profit+	25.82M	29.35M	32.25M	30.42M	18.18M	3.71M	416.88K	9.14K	9.02K
Gross Margin %	0.49%	0.48%	0.5%	0.47%	0.25%	0.04%	0.02%	0%	0.13%
Gross Profit Growth %	-	0.14%	0.1%	-0.06%	-0.4%	-0.8%	-0.89%	-0.98%	-0.01%
Operating Expenses+	8.61M	9.11M	10.4M	15.02M	16.65M	51.29M	4.97M	4.63M	6.79M
OpEx % of Revenue	0.16%	0.15%	0.16%	0.23%	0.23%	0.57%	0.21%	0.71%	94.95%
Selling, General & Admin	6.96M	7.25M	8.24M	12.66M	14.99M	49.6M	64.18M	2.82M	2.31M
SG&A % of Revenue	0.13%	0.12%	0.13%	0.19%	0.21%	0.55%	2.75%	0.43%	32.26%
Research & Development	1.66M	1.86M	2.16M	2.36M	1.66M	1.68M	1.4M	0	0
R&D % of Revenue	0.03%	0.03%	0.03%	0.04%	0.02%	0.02%	0.06%	-	-
Other Operating Expenses	0	0	103.77K	0	0	0	-60.61M	1.81M	4.48M
Operating Income+	17.21M	20.24M	21.84M	15.4M	1.53M	-47.58M	-4.55M	-4.62M	-6.78M
Operating Margin %	0.32%	0.33%	0.34%	0.24%	0.02%	-0.53%	-0.19%	-0.71%	-94.82%
Operating Income Growth %	-	0.18%	0.08%	-0.3%	-0.9%	-32.18%	0.9%	-0.02%	-0.47%
EBITDA+	17.33M	20.36M	22.53M	16.07M	2.41M	-45.39M	-4.49M	-4.24M	-6.4M
EBITDA Margin %	0.33%	0.33%	0.35%	0.25%	0.03%	-0.51%	-0.19%	-0.65%	-89.51%
EBITDA Growth %	-	0.17%	0.11%	-0.29%	-0.85%	-19.86%	0.9%	0.06%	-0.51%
D&A (Non-Cash Add-back)	125.92K	119.76K	682.46K	674.25K	880.88K	2.19M	58.75K	381.13K	380K
EBIT	17.51M	20.49M	21.99M	15.63M	1.76M	-57.66M	-4.53M	-3.75M	-6.74M
Net Interest Income+	-482.1K	-114.57K	-41.51K	-23.16K	20.1K	22.4K	316	-38.82K	-261.7K
Interest Income	11.62K	18.71K	42.04K	74.93K	131.9K	108.39K	316	345	156
Interest Expense	493.73K	133.28K	83.55K	98.09K	111.8K	85.99K	0	39.17K	261.85K
Other Income/Expense	-184.66K	120.85K	62.26K	133.41K	125.62K	-10.17M	22.04K	831.48K	-219.09K
Pretax Income+	17.02M	20.36M	21.91M	15.53M	1.65M	-57.75M	-4.53M	-3.79M	-7M
Pretax Margin %	0.32%	0.33%	0.34%	0.24%	0.02%	-0.65%	-0.19%	-0.58%	-97.88%
Income Tax+	2.5M	2.87M	3.18M	2.84M	959.38K	-3.73M	3K	0	0
Effective Tax Rate %	0.85%	0.86%	0.85%	0.82%	0.48%	0.85%	15.85%	2.67%	1.13%
Net Income+	14.52M	17.49M	18.72M	12.69M	786.36K	-49.19M	-71.74M	-10.13M	-7.89M
Net Margin %	0.27%	0.28%	0.29%	0.2%	0.01%	-0.55%	-3.07%	-1.55%	-110.33%
Net Income Growth %	-	0.2%	0.07%	-0.32%	-0.94%	-63.56%	-0.46%	0.86%	0.22%
Net Income (Continuing)	14.52M	17.49M	18.72M	12.69M	691.96K	-54.02M	-4.53M	-3.79M	-7M
Discontinued Operations	0	0	0	0	0	0	-67.66M	-6.14M	-1.3M
Minority Interest	0	0	0	0	2.89M	-710.75K	-886.01K	-412.18K	4.75M
EPS (Diluted)+	11.61	13.99	14.98	10.60	0.03	-24.30	-12.63	-2.14	-0.08
EPS Growth %	-	0.2%	0.07%	-0.29%	-1%	-811.01%	0.48%	0.83%	0.96%
EPS (Basic)	11.61	13.99	14.98	10.60	0.03	-24.30	-12.63	-2.14	-0.08
Diluted Shares Outstanding	1.25M	1.25M	1.25M	1.19M	26.16M	2.02M	5.68M	4.73M	84.51M
Basic Shares Outstanding	1.25M	1.25M	1.25M	1.19M	26.16M	2.02M	5.68M	4.73M	84.51M
Dividend Payout Ratio	-	0.48%	-	-	-	-	-	-	-

Balance Sheet

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Current Assets+	32.22M	43.76M	54.84M	69.98M	95.1M	56.57M	9.79M	2.85M	7.19M
Cash & Short-Term Investments	4.27M	8.88M	14.8M	33.65M	36.56M	19.73M	2.05M	944.24K	5.02M
Cash Only	4.27M	8.88M	14.8M	33.65M	36.56M	19.73M	3.36M	944.24K	261.36K
Short-Term Investments	0	0	0	0	0	0	0	0	4.76M
Accounts Receivable	24.14M	32.56M	32.01M	30.04M	34.56M	29.23M	2M	285.75K	0
Days Sales Outstanding	166.26	193.28	182.75	168.51	176.48	119.23	31.29	15.94	-
Inventory	3.73M	2.27M	1.97M	2.03M	1.79M	1.39M	335.02K	0	653.34K
Days Inventory Outstanding	50.04	25.77	22.7	21.38	12.22	5.91	1.31	-	3.81K
Other Current Assets	0	11.13K	6.06M	699.42K	3.07M	226.17K	4.17M	47.35K	12.21K
Total Non-Current Assets+	9.31M	9.64M	10.84M	15.11M	17.65M	40.86M	26.55M	4.88M	28.38M
Property, Plant & Equipment	8.52M	8.79M	7.81M	7.9M	10.51M	11.25M	8.47M	12.6K	126.44K
Fixed Asset Turnover	6.22x	7.00x	8.19x	8.24x	6.80x	7.96x	2.75x	519.60x	0.57x
Goodwill	0	0	0	0	162.83K	10.08M	6.46M	3.38M	17.5M
Intangible Assets	789.09K	847.5K	774.37K	719.72K	1.83M	10.1M	9.45M	1.49M	10.75M
Long-Term Investments	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	2.26M	6.5M	5.14M	5.63M	2.18M	0	0
Total Assets+	41.53M	53.4M	65.68M	85.1M	112.74M	97.43M	36.34M	7.73M	35.56M
Asset Turnover	1.28x	1.15x	0.97x	0.76x	0.63x	0.92x	0.64x	0.85x	0.00x
Asset Growth %	-	0.29%	0.23%	0.3%	0.32%	-0.14%	-0.63%	-0.79%	3.6%
Total Current Liabilities+	18.01M	8.84M	4.76M	5.51M	15.11M	17.93M	20.95M	2.56M	6.4M
Accounts Payable	6.06M	5.4M	1.66M	1.55M	8.84M	12.16M	13.46M	0	1.73M
Days Payables Outstanding	81.4	61.3	19.17	16.32	60.53	51.73	52.78	-	10.12K
Short-Term Debt	1.45M	1.49M	1.04M	2.03M	2.24M	2.27M	2.24M	2.29M	2.25M
Deferred Revenue (Current)	0	0	0	0	0	1000K	1000K	0	73.32K
Other Current Liabilities	10.21M	1.95M	2.06M	1.93M	4.02M	196.09K	122.78K	66.68K	0
Current Ratio	1.79x	4.95x	11.51x	12.71x	6.29x	3.15x	0.47x	1.11x	1.12x
Quick Ratio	1.58x	4.69x	11.10x	12.34x	6.18x	3.08x	0.45x	1.11x	1.02x
Cash Conversion Cycle	134.9	157.75	186.28	173.56	128.17	73.42	-20.18	-	-
Total Non-Current Liabilities+	209.01K	0	0	0	0	2.08M	1.51M	0	158.09K
Long-Term Debt	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	209.01K	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0	2.08M	1.51M	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	158.09K
Total Liabilities	18.21M	8.84M	4.76M	5.51M	15.11M	20.01M	22.47M	2.56M	6.56M
Total Debt+	1.95M	1.49M	1.04M	2.03M	2.24M	2.27M	2.24M	2.29M	2.35M
Net Debt	-2.32M	-7.39M	-13.76M	-31.62M	-34.32M	-17.47M	-1.11M	1.34M	2.09M
Debt / Equity	0.08x	0.03x	0.02x	0.03x	0.02x	0.03x	0.16x	0.44x	0.08x
Debt / EBITDA	0.11x	0.07x	0.05x	0.13x	0.93x	-	-	-	-
Net Debt / EBITDA	-0.13x	-0.36x	-0.61x	-1.97x	-14.26x	-	-	-	-
Interest Coverage	34.85x	151.86x	261.44x	156.99x	13.65x	-553.25x	-	-118.00x	-25.91x
Total Equity+	23.31M	44.55M	60.92M	79.59M	97.64M	77.41M	13.87M	5.17M	29M
Equity Growth %	-	0.91%	0.37%	0.31%	0.23%	-0.21%	-0.82%	-0.63%	4.61%
Book Value per Share	18.65	35.64	48.73	66.76	3.73	38.24	2.44	1.09	0.34
Total Shareholders' Equity	23.31M	44.55M	60.92M	79.59M	94.75M	78.13M	14.76M	5.58M	24.26M
Common Stock	11.5K	11.5K	11.5K	12.5K	15.24K	39.55K	83.3K	73.3K	673.3K
Retained Earnings	17.78M	35.27M	53.94M	66.62M	61.48M	12.29M	-59.45M	-61.96M	-70.26M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	1.02M	4.2M	1.27M	-2.09M	6.71M	11.93M	7.22M	2.55M	2.53M
Minority Interest	0	0	0	0	2.89M	-710.75K	-886.01K	-412.18K	4.75M

Cash Flow

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operations+	11.32M	12.93M	6.54M	10.78M	2.9M	-28.13M	-20.71M	-13.11M	-2.67M
Operating CF Margin %	0.21%	0.21%	0.1%	0.17%	0.04%	-0.31%	-0.89%	-2%	-37.31%
Operating CF Growth %	-	0.14%	-0.49%	0.65%	-0.73%	-10.69%	0.26%	0.37%	0.8%
Net Income	14.52M	17.49M	18.72M	12.69M	691.96K	-54.02M	-71.74M	-9.93M	-8.31M
Depreciation & Amortization	142.97K	137.17K	699.54K	690.75K	880.88K	2.19M	31.67K	381.13K	380K
Stock-Based Compensation	0	0	0	0	778.42K	1.09M	0	0	0
Deferred Taxes	0	0	0	0	2.56M	-3.92M	0	0	0
Other Non-Cash Items	3.78M	4.95M	-3.15K	117.79K	-2.56M	11.4M	51M	-2.4M	5.16M
Working Capital Changes	-3.34M	-4.69M	-12.87M	-2.72M	553.21K	15.13M	6.34K	-1.16M	100.12K
Change in Receivables	-4.35M	-6.55M	-1.6M	393.14K	-2.11M	23.22M	0	-11.36K	0
Change in Inventory	-184.4K	2.3M	148.39K	-276.91K	389.39K	454.26K	0	0	0
Change in Payables	1.13M	-1.19M	-3.38M	-32.72K	6.72M	-4.85M	0	0	0
Cash from Investing+	-1.1M	-157.97K	-277.16K	-1.16M	-13.22M	-8.48M	89.32K	11.7M	-27.05M
Capital Expenditures	-1.1M	-157.97K	-283.1K	-1.16M	-3.83M	-2.41M	0	0	0
CapEx % of Revenue	0.02%	0%	0%	0.02%	0.05%	0.03%	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	25.9K	89.32K	11.7M	-4.76M
Cash from Financing+	-8.43M	-8.78M	271.11K	10.4M	10.67M	18.83M	3.15M	0	29.01M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-8.33M	0	0	-375K	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-8.59M	221.42K	627.63K	0	37.52K	0	3.15M	0	1.85M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	10.22M	12.78M	6.26M	9.62M	-930.11K	-30.54M	-20.71M	-11.88M	-2.67M
FCF Margin %	0.19%	0.21%	0.1%	0.15%	-0.01%	-0.34%	-0.89%	-1.81%	-37.31%
FCF Growth %	-	0.25%	-0.51%	0.54%	-1.1%	-31.84%	0.32%	0.43%	0.78%
FCF per Share	8.17	10.22	5.01	8.07	-0.04	-15.09	-3.65	-2.51	-0.03
FCF Conversion (FCF/Net Income)	0.78x	0.74x	0.35x	0.85x	3.69x	0.57x	0.29x	1.29x	0.34x
Interest Paid	148.16K	133.28K	83.55K	98.09K	111.79K	0	0	0	0
Taxes Paid	2.33M	2.92M	3.01M	3.18M	1.21M	0	0	90.74K	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	62.27%	51.54%	35.5%	18.06%	0.89%	-56.2%	-157.17%	-106.36%	-46.2%
Return on Invested Capital (ROIC)	61.48%	52.21%	38.86%	24.28%	2.06%	-57.89%	-9.38%	-35.97%	-27.06%
Gross Margin	48.71%	47.73%	50.44%	46.75%	25.43%	4.15%	1.79%	0.14%	12.6%
Net Margin	27.39%	28.44%	29.28%	19.5%	1.1%	-54.97%	-307.47%	-154.72%	-11033.03%
Debt / Equity	0.08x	0.03x	0.02x	0.03x	0.02x	0.03x	0.16x	0.44x	0.08x
Interest Coverage	34.85x	151.86x	261.44x	156.99x	13.65x	-553.25x	-	-118.00x	-25.91x
FCF Conversion	0.78x	0.74x	0.35x	0.85x	3.69x	0.57x	0.29x	1.29x	0.34x
Revenue Growth	-	16.04%	3.97%	1.76%	9.87%	25.19%	-73.93%	-71.95%	-98.91%

Frequently Asked Questions

Growth & Financials

Paranovus Entertainment Technology Ltd. (PAVS) reported $6.6M in revenue for fiscal year 2024. This represents a 88% decrease from $53.0M in 2016.

Paranovus Entertainment Technology Ltd. (PAVS) saw revenue decline by 98.9% over the past year.

Paranovus Entertainment Technology Ltd. (PAVS) reported a net loss of $18.0M for fiscal year 2024.

Dividend & Returns

Paranovus Entertainment Technology Ltd. (PAVS) has a return on equity (ROE) of -46.2%. Negative ROE indicates the company is unprofitable.

Paranovus Entertainment Technology Ltd. (PAVS) had negative free cash flow of $14.5M in fiscal year 2024, likely due to heavy capital investments.